NeFCM Trademark (Class 5) — Opposed Status & Details
Source: Indian Trademark Registry (ipindia.gov.in) · IP India record as of 25/05/2026 · Indexed 2026-05-25 · Last updated 25 May 2026
Trademark Fact Sheet
Goods & Services
Pharmaceuticals; Antibacterialpharmaceuticals;Homeopathic pharmaceuticals; Capsules, empty,forpharmaceuticals; Pharmaceuticals, medicalandveterinary,preparations; Capsules sold empty forpharmaceuticals;Pharmaceuticals for treating respiratory diseases;Pharmaceuticalsfor the treatment of cancer; Pharmaceuticals for thetreatment ofinfectious diseases; Pharmaceuticals for the treatment oferectiledysfunction; Pharmaceuticals for the treatment of viraldiseases;Pharmaceuticals for the treatment of bone diseases; Skinpatches forthe transdermal delivery of pharmaceuticals;Injectablepharmaceutical s for treatment of anaphylactic reactions;Capsulesmade of dendrimerbased polymers, forpharmaceuticals;Pharmaceuticals for the prevention and treatment ofcancer;Pharmaceuticals for treating the symptoms of radiationsickness;Drug delivery agents in the form of edible wafers forwrappingpowdered pharmaceuticals; Drug delivery agents consistingofcompounds that facilitate delivery of a wide rangeofpharmaceuticals; Drug delivery agents in the form of powdersthatprovide controlled release of the active ingredients for a widevarietyof pharmaceuticals.
Owner
- Name
- PATUM BABU SUBUDHI Single Firm1 trademark filed under this owner
- Address
- *****, ODISHA-761042
- ****erveindia.com
- State
- Odisha
Application Timeline
Uploaded Documents
12 documents filed with the Trade Marks Registry for this application.
| # | Document | Date |
|---|---|---|
| 1 | TM-A(TRADE MARKS APPLICATION) | 11 Nov 2022 |
| 2 | TM-M(EXPEDITED EXAMINATION) | 30 Nov 2022 |
| 3 | Reply to Exam Report (MIS-R) | 3 Dec 2022 |
| 4 | Authorization Letter | 9 Jan 2023 |
| 5 | Letters related to TLA | 9 Jan 2023 |
| 6 | TM-M(REQUEST FOR PAYMENT OF MISC. FEE FOR OTHER PURPOSE) | 25 Jan 2023 |
| 7 | Documents in support of Show cause Hearing (SCH) | 4 Mar 2023 |
| 8 | Authorization Letter | 6 Mar 2023 |
| 9 | Journal Copy | 8 Jun 2023 |
| 10 | TM-O(NOTICE OF OPPOSITION) | 10 Aug 2023 |
| 11 | Annexure -1 under rule 46 | 22 May 2026 |
| 12 | Evidence Affidavit Under Rule 46 (TOP) | 22 May 2026 |
Correspondence and Notices
6 notices issued by the Registry on this application.
| # | Subject | Corres. No. | Date |
|---|---|---|---|
| 1 | EXAMINATION REPORT | 14419445 | 1 Dec 2022 |
| 2 | Hearing Notice (Show Cause) | 14527934 | 22 Dec 2022 |
| 3 | Hearing Notice (Show Cause) | 14706284 | 27 Jan 2023 |
| 4 | Tribunal Accepted Notice for : 5677575 | 15038320 | 30 Mar 2023 |
| 5 | Opposition Notice | 15835755 | 14 Aug 2023 |
| 6 | Opposition Counter Statement | 16648930 | 28 Nov 2023 |
Filing claims & diligence
- First use claim
- Proposed to be used
- Filing mode
- e-Filing
- Category
- TRADE MARK
Attorney / IP Agent
- Name & code
- NEWTON REGINALD[25853]
- Address
- *****, Dhanammal Street Spurtank Road Chetpet Chennai - 600031
Opposition history
| Date | Opp. Number | Opponent Code | Opponent Name & Address |
| 10/08/2023 | [1234224] | [2020972] | ERIS LIFESCIENCES LIMITED Shivarth Ambit, Plot No 142/2, Ramdas Road, Off. SBR, Near Swati Bungalows, Bodakdev, Ahmedabad – 380054. |
What does this status mean?
NeFCM has been opposed by a third party in Class 5. The applicant must file a counter-statement and defend the mark, or it will be deemed abandoned. Oppositions can be contested with the right support.
Frequently asked questions
The trademark NeFCM (Application No. 5677575) is owned by (1) PATUM BABU SUBUDHI Single Firm, as recorded in the Indian Trademark Registry. Trademark ownership in India is determined by the Trade Marks Act, 1999 and the Trade Marks Rules, 2017.
The current status of NeFCM is "Opposed". It was filed on 11/11/2022 at KOLKATA in Class 5. Status may change over time as the application moves through examination, publication, opposition and registration stages.
NeFCM is filed in Class 5, covering: Pharmaceuticals; Antibacterialpharmaceuticals;Homeopathic pharmaceuticals; Capsules, empty,forpharmaceuticals; Pharmaceuticals, medicalandveterinary,preparations; Capsules sold empty forpharmaceuticals;Pharmaceuticals for treating respiratory diseases;Pharmaceuticalsfor the treatment of cancer; Pharmaceuticals for thetreatment ofinfectious diseases; Pharmaceuticals for the treatment oferectiledysfunction; Pharmaceuticals for the treatment of viraldiseases;Pharmaceuticals for the treatment of bone diseases; Skinpatches forthe transdermal delivery of pharmaceuticals;Injectablepharmaceutical s for treatment of anaphylactic reactions;Capsulesmade of dendrimerbased polymers, forpharmaceuticals;Pharmaceuticals for the prevention and treatment ofcancer;Pharmaceuticals for treating the symptoms of radiationsickness;Drug delivery agents in the form of edible wafers forwrappingpowdered pharmaceuticals; Drug delivery agents consistingofcompounds that facilitate delivery of a wide rangeofpharmaceuticals; Drug delivery agents in the form of powdersthatprovide controlled release of the active ingredients for a widevarietyof pharmaceuticals.
NeFCM covers: Pharmaceuticals; Antibacterialpharmaceuticals;Homeopathic pharmaceuticals; Capsules, empty,forpharmaceuticals; Pharmaceuticals, medicalandveterinary,preparations; Capsules sold empty forpharmaceuticals;Pharmaceuticals for treating respiratory diseases;Pharmaceuticalsfor the treatment of cancer; Pharmaceuticals for thetreatment ofinfectious diseases; Pharmaceuticals for the treatment oferectiledysfunction; Pharmaceuticals for the treatment of viraldiseases;Pharmaceuticals for the treatment of bone diseases; Skinpatches forthe transdermal delivery of pharmaceuticals;Injectablepharmaceutical s for treatment of anaphylactic reactions;Capsulesmade of dendrimerbased polymers, forpharmaceuticals;Pharmaceuticals for the prevention and treatment ofcancer;Pharmaceuticals for treating the symptoms of radiationsickness;Drug delivery agents in the form of edible wafers forwrappingpowdered pharmaceuticals; Drug delivery agents consistingofcompounds that facilitate delivery of a wide rangeofpharmaceuticals; Drug delivery agents in the form of powdersthatprovide controlled release of the active ingredients for a widevarietyof pharmaceuticals.
The exact word "NeFCM" is already on record at the Indian Trademark Registry under Application No. 5677575. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.
Indian registered trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks. NeFCM (App #5677575) is currently in status "Opposed" — renewal dates apply only after registration is granted.
If NeFCM is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.
— Public Notice —
Protect a mark like "NeFCM"
Free availability check, attorney drafting, and end-to-end TM-A filing through Registerkaro. Pick the plan that fits — government fee additional.
For individuals or companies who just want to file a trademark.
- Help choosing the right trademark class
- Drafting & Filing by TM Expert + Power of Attorney form
- Acknowledgement Receipt
- TM usage guide